logo
What are the Mega Millions numbers for Tuesday, July 15? Jackpot stands at $90 million

What are the Mega Millions numbers for Tuesday, July 15? Jackpot stands at $90 million

Yahoo15-07-2025
Have you gotten your tickets yet? Tuesday, July 15, Mega Millions jackpot stands at $90 million with a $39.9 million cash option.
Here's what to know about the Mega Millions:
Tuesday, July 15, winning numbers will be drawn at around 11 p.m. ET.
Friday, July 11, winning numbers were 12-23-24-31-56 and the Megaball was 1.
There were no jackpot winners Friday, July 11.
You only need to match one number in Mega Millions to win a prize. However, that number must be the Mega Ball, worth $2.
Matching two numbers won't win anything in Mega Millions unless one of the numbers is the Mega Ball. A ticket matching one of the five numbers and the Mega Ball is worth $4. Visit www.megamillions.com for a complete list of payout information.
Mega Millions numbers you need to know: Most commonly drawn numbers
Drawings are held two times per week at approximately 11 p.m. ET every Tuesday and Friday. You can watch drawings via YouTube.
A Mega Millions ticket costs $2 per play. For an additional $1, players can add the Megaplier to potentially increase their winnings outside of the jackpot.
Here's how to play Mega Millions:
Here is the list of 18 Mega Millions jackpot wins in 2023 through 2025, according to megamillions.com:
$348 million — June, 27, 2025; Virginia
$112 million — April, 18, 2025; Ohio
$344 million — March 25, 2025; Illinois
$113 million — Jan. 17, 2025; Arizona
$1.22 billion — Dec. 27, 2024; California
$800 million — Sept. 10, 2024; Texas.
$560 million — June 4, 2024; Illinois.
$1.12 billion — March 26, 2024; New Jersey.
$1.35 billion — Jan. 13, 2024; Maine.
$20 million — Jan. 17, 2024; New York.
$31 million — Jan. 24; Massachusetts.
$31 million — Jan. 31; Massachusetts.
$483 million — April 14; New York.
$20 million — April 18; New York.
$1.58 billion — Aug. 8, 2023; Florida.
$36 million — Aug. 15, 2023; Florida.
$360 million — Oct. 6, 2023: Texas.
$395 million — Dec. 8, 2023; California (2).
Here are the all-time top 11 Mega Millions jackpots, according to megamillions.com:
$1.58 billion — Aug. 8, 2023; Florida.
$1.537 billion — Oct. 23, 2018; South Carolina.
$1.35 billion — Jan. 13, 2023; Maine.
$1.337 billion — July 29, 2022; Illinois.
$1.22 billion — Dec. 31, 2024; California
$1.05 billion — Jan. 22, 2021; Michigan.
$656 million — Mar. 30, 2012; Kansas, Illinois, Maryland.
$648 million — Dec. 17, 2013; California, Georgia.
$560 million — June 4, 2024; Illinois.
$543 million — July 24, 2018; California.
$536 million — July 8, 2016; Indiana.
This article originally appeared on Louisville Courier Journal: Mega Millions numbers: Winning numbers for 7-15-25; jackpot at $90M
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hudbay Minerals (HBM) Climbs 15% on Stellar Earnings, $600-Million Investment From Mitsubishi
Hudbay Minerals (HBM) Climbs 15% on Stellar Earnings, $600-Million Investment From Mitsubishi

Yahoo

time13 minutes ago

  • Yahoo

Hudbay Minerals (HBM) Climbs 15% on Stellar Earnings, $600-Million Investment From Mitsubishi

We recently published . Hudbay Minerals Inc. (NYSE:HBM) is one of the best-performing stocks on Wednesday. Hudbay Minerals grew its share prices for a second day on Wednesday, up 15.03 percent to close at $11.33 apiece, following an impressive earnings performance and a $600-million investment from Mitsubishi Corp. In its updated report, Hudbay Minerals Inc. (NYSE:HBM) said it swung to a net income attributable to shareholders of $117.7 million from an attributable net loss of $16.5 million in the same period last year, driven by higher gross margins and strong cost control. Revenues increased by 26 percent to $536.4 million from $425.5 million year-on-year. 'With the strong performance in the first half of the year, we are reaffirming our full year consolidated production guidance and are favourably tracking well below our full year consolidated cost guidance for 2025,' said Hudbay Minerals Inc. (NYSE:HBM) President and CEO Peter Kukielski. For the full-year period, the company is targeting to produce between 117,000 and 149,000 tons of copper, as well as 247,500 to 308,000 ounces of gold. In other news, Hudbay Minerals Inc. (NYSE:HBM) was able to raise $600 million in fresh funds from Mitsubishi Corp. after the latter acquired a 30-percent stake in Copper World LLC. Under the agreement, Mitsubishi will pay an upfront cash of $420 million, with the balance to serve as a matching contribution within an 18-month period. While we acknowledge the potential of HBM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Paramount Skydance (PSKY) Soars 60% to New High. Time to Book Gains?
Paramount Skydance (PSKY) Soars 60% to New High. Time to Book Gains?

Yahoo

time13 minutes ago

  • Yahoo

Paramount Skydance (PSKY) Soars 60% to New High. Time to Book Gains?

We recently published . Paramount Skydance Corp. (NASDAQ:PSKY) is one of the best-performing stocks on Wednesday. Paramount Skydance extended its rally to touch a new high on Wednesday, finishing up by 36.74 percent at $15 apiece, with a former hedge fund manager calling it a 'meme' stock. In a social media post, Mad Money host and former hedge fund manager Jim Cramer said Paramount Skydance Corp. (NASDAQ:PSKY) is a 'meme stock' given the company's small public float and unjustifiable rally amid the lack of fresh developments. Paramount Skydance Corp. (NASDAQ:PSKY) climbed by as high as 60 percent at intra-day trading to hit $17.53 before paring gains to finish slightly lower during the session. In recent news, the company bagged a new $7.7-billion deal to exclusively air the Ultimate Fighting Championship (UFC) on Paramount+ for seven years beginning in 2026. The deal would include UFC's full slate of 13 marquee numbered events and 30 Fight Nights through its direct-to-consumer streaming platform, Paramount+, with select numbered events to be simulcast on CBS. cellanr, CC BY-SA 2.0 , via Wikimedia Commons As part of the agreement, Paramount Skydance Corp. (NASDAQ:PSKY) will move UFC away from the existing Pay-Per-View model and make the latter available at no additional cost to Paramount+ subscribers in the US. It also intends to explore UFC rights outside the US in the future. While we acknowledge the potential of PSKY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results
ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results

Yahoo

time13 minutes ago

  • Yahoo

ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results

We recently published . ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best-performing stocks on Wednesday. ImmunityBio soared by 14.17 percent on Wednesday to close at $2.82 apiece as investors cheered promising early findings from its ongoing trial (QUILT-106) to treat a rare blood cancer type with its therapy candidate. In a statement, ImmunityBio, Inc. (NASDAQ:IBRX) said the first phase of QUILT-106 showed highly promising results in the first two patients with Waldenstrom macroglobulinemia (WM)—a type of non-Hodgkins lymphoma (NHL)—using its CD19 CAR-NK (CD19 t-haNK) natural killer cell therapy. The trial aims to evaluate the safety and efficacy of the cell therapy alone, as well as when it is combined with an existing drug called rituximab. According to ImmunityBio, Inc. (NASDAQ:IBRX), both patients tolerated the therapy candidate without any significant side effects. Notably, all infusions were administered in an outpatient setting. Copyright: katrintimoff / 123RF Stock Photo 'One patient achieved a complete response (CR) with CD19 CAR NK monotherapy, while the second patient achieved CR with CD19 CAR-NK in combination with rituximab. Remission was maintained and is ongoing for six months to date,' ImmunityBio, Inc. (NASDAQ:IBRX) said. While we acknowledge the potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store